Skip to main content
. 2017 Apr 10;8(20):33807–33826. doi: 10.18632/oncotarget.16995

Figure 11. U0126 administration preserves the expression of two key urate transporters.

Figure 11

(A) The kidney tissue lysates were subjected to immunoblot analysis with specific antibodies against OAT1, OAT3 or glyceraldehyde 3-phosphate dehydrogenase (GAPDH). (B) Expression level of OAT1 was quantified by densitometry and normalized with GAPDH. (C) Expression level of OAT3 was quantified by densitometry and normalized with GAPDH. Data are represented as the mean±SEM (n=6). Means with different letters are significantly different from one another (P<0.05).